Resumen: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by pruritus, eczematous lesions, and lichenification. Treating patients with severe forms of AD is generally challenging for dermatologists. Here, we describe a case of tralokinumab-related facial redness in a patient who had a good response to the drug previously. Idioma: Inglés DOI: 10.1111/ijd.17231 Año: 2024 Publicado en: INTERNATIONAL JOURNAL OF DERMATOLOGY 63, 11 (2024), 1605-1606 ISSN: 0011-9059 Factor impacto JCR: 3.2 (2024) Categ. JCR: DERMATOLOGY rank: 22 / 96 = 0.229 (2024) - Q1 - T1 Factor impacto SCIMAGO: 0.822 - Dermatology (Q1)